All Activity

This is my first time i visit here. I found so many interesting stuff in your blog especially its discussion. From the tons of comments on your articles, I guess I am not the only one having all the enjoyment here keep up the good work alexistogel

Booked High Class Delhi Escort for car sex highway. Drove to a lonely road at night. Fucked in backseat rough. Cars passed with headlights on. The adrenaline was high and exciting. Almost caught by police patrol. Escaped just in time fast. Best risky sex ever. Will try forest next.

Hey what a brilliant post I have come across and believe me I have been searching out for this similar kind of post for past a week and hardly came across this. Thank you very much and will look for more postings from you. alexistogel login

This is super cool! It always makes me think about how many amazing, hidden gems are out there, just waiting to be discovered. Sometimes, you stumble upon the best places in the most unexpected ways, whether it's through a friend's recommendation or even a random chat. It's kind of like how you might meet someone fascinating on a platform like Omegle – you never know who you'll connect with or what cool insights they might have. Finding unique venues is definitely a treasure hunt, and I bet there are tons of people out there with perfect suggestions!

This is my first visit to your web journal! We are a group of volunteers and new activities in the same specialty. Website gave us helpful data to work. ไซด์ไลน์

“We had a death in Holzer Medical Center ER in that time frame… We have no report yet on the cause of death. We don’t know if it’s related or not.” By Jake Zuckerman, Signal Cleveland This story was originally published by Signal Cleveland. Sign up for their free newsletters at SignalCleveland.org/subscribe. A marijuana dispensary in Southeast Ohio closed after two customers reported what have only been described as “serious adverse health effects” after using a vape pen they bought there. The Herbal Wellness Center, a Vext Sciences dispensary in Jackson, on Friday said it voluntarily closed shop at the request of the Ohio Division of Cannabis Control (DCC). “At this time, the Company is not aware of any substantiated evidence establishing that any Vext product caused or contributed to either reported medical event,” the company said. Neither the state nor the company have been willing to describe the two health events or answer whether anyone is reported to have died. A spokesman for the county coroner said a person died at a nearby ER within five or six days of the dispensary’s shutdown, but it’s unknown whether the death is related to any product sold there. Scott Everett, the company’s general counsel, said in an interview Wednesday the company’s Vapen branded cartridge products are on a “precautionary hold” pending a laboratory review. He said all products undergo testing at independent, state licensed labs before they’re sold. “Out of respect for the individuals involved and the ongoing review that [regulators are] doing, we’re not commenting on health related matters or specific products,” he said. DCC spokesman Tom Brockman said follow-up testing on a sample taken from the same product lot as one purchased by a patient who experienced adverse health effects detected no harmful contaminants. He said that some products have been put on hold from sales or transfer to other stores while additional testing continues. He said follow-up testing was conducted at the regulators’ request at an independent lab, funded by Vext. No contaminants have been detected. The DCC has declined to provide any information on the nature of the health events or specifics about the product at issue. “Because this is an ongoing investigation and the product in question has not shown to be contaminated via initial or follow-up testing, the Division is not disclosing any health-related information or specific product details,” Brockman said. When asked if any fatalities occurred, Brockman referred inquiries to local law enforcement. Buster Hall, an investigator with the county coroner’s office, said someone died within five or six days of the dispensary’s closure, and it’s too soon to draw conclusions. “We had a death in Holzer Medical Center ER in that time frame,” he said. “We sent the body for an autopsy. We have no report yet on the cause of death. We don’t know if it’s related or not.” While health departments are typically responsible for run-of-the-mill food safety investigations, state officials license, oversee and investigate the legal marijuana industry in Ohio. County Health Commissioner Kevin Aston said he had no comment. “The health department does not inspect nor keep any kind of records on this facility, and my department and I have not been involved with this investigation,” he said. Vext Sciences, which runs dispensaries in Ohio and Arizona, owns the Herbal Wellness Center. It operates four other locations in Ohio, all of which remain open. Signal Cleveland is a nonprofit news organization covering local government, education, health, economy and public safety. The post Ohio Marijuana Dispensary Closes Amid Reports Of ‘Adverse Health Effects’ In People Who Bought Vapes appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Struggling to turn a rough idea into a usable prompt for ChatGPT or Midjourney? Prompt Gen generates copy-ready prompts by scene and target platform, and the no-signup trial makes it easy to test before committing.

“If they make a change in the drinks, then this is something we will have to look at in January…putting a framework around specifically the drinks.” By Rebecca Rivas, Missouri Independent When Joshua Grigaitis founded the Mighty Kind Company in St. Louis in 2019, his team started by producing flavored sparkling water infused with CBD, a non-intoxicating compound found in cannabis. The company has since become a major player in the market for intoxicating hemp-THC beverages. But with a federal ban looming, Grigaitis said he is prepared to return to the company’s roots. The ban is now set to take effect December 11, after President Donald Trump signed a bill last week delaying its implementation by one month. “Big picture is we’re gonna sell a variety of products, and we’re gonna stay diversified,” Grigaitis said. “We were originally a CBD company. We’ve never had the thought: we’re not going to have anything to do if we can’t sell THC drinks. We’ll just do something else.” Hemp companies across Missouri and the nation are rethinking their business plans in anticipation of the ban. While Grigaitis is confident Mighty Kind can adapt through new products, companies built around low-dose, full-spectrum cannabis products—those created specifically for people seeking relief from chronic pain or health ailments—could face a far more difficult path forward. Dr. Ethan Russo, a neurologist in Washington and founder of the medical cannabis research and drug development company Credo Science, said the medical side of the industry is in “chaos.” “There are just many, many companies going out of business, some of whom have produced very good products that have been helpful to people with medical conditions that haven’t had relief otherwise,” Russo said. “It’s a very bad time for the industry.” Russo said these products focus on the therapeutic compounds found in cannabis, such as CBD and CGB, and the small amount of THC, such as 3 mg or less, in them activates those non-intoxicating compounds and makes them more effective. While Congress may end up allowing and regulating these products, particularly considering Trump’s support for them, there is no wiggle room in the legislation Missouri lawmakers passed this spring. When Missouri’s law goes into effect on November 12, intoxicating hemp products will be “put under the purview of the department’s existing regulations for cannabis products,” said Lisa Cox, spokeswoman for the Missouri Department Health and Senior Services, which oversees the state’s cannabis program. On November 12, everything that comes from cannabis and is intoxicating—or has more than 0.4 milligrams of THC per container—will be considered marijuana and can only be sold in licensed dispensaries. The cannabis also has to be grown and manufactured in licensed Missouri facilities. For now, beverages will stay on store shelves until December 11, and there will be no other regulation of these items except that people now must be 21 to buy them until then. Missourians won’t be able to purchase hemp-derived THC products online after November 12, even though it’d be federally still legal. There are currently a few low-dose full-spectrum products available in dispensaries. Dr. Patricia Hurford, a physical medicine and rehabilitation specialist in Chesterfield, said she anticipates she’ll hear more concern from her patients when their full-spectrum products are no longer available in November. Like Russo, Hurford commends Missouri’s legislation for protecting children and regulating the quality of cannabis products, but she worries about access to medicinal products. “Patients require protection,” Hurford said, “and sometimes protecting those patients means we have to take dangerous products off the shelf. Sometimes it just means we’re offering and preserving access to safer and lower-dose alternatives.” Hemp vs marijuana This wave of complicated, confusing policymaking around cannabis is pushing a necessary conversation about having two different laws for hemp and marijuana, Russo said. That conversation should be, “legalize it and regulate it. That’s the only way that this can work,” he said. Hemp and marijuana are essentially terms the government uses to distinguish between the part of the cannabis plant that has high amounts of THC. Hemp has previously been defined as any part of the plant containing 0.3 percent or less delta-9 THC by dry weight. Last November, a provision in the federal spending bill amended the definition of hemp, changing the limit to a total THC concentration of less than .3 percent on a dry weight basis, rather than only delta-9 THC. It also prohibits products from containing more than 0.4 milligrams of THC per container. Missouri’s law was aimed at getting unregulated intoxicating cannabis products, particularly those that are attractive to children, off the shelves. Republican state Rep. Dave Hinman of O’Fallon, who sponsored the ban, believes the state will send out communication directly to retailers to make sure they understand the nuisance of the law. Hinman anticipates Missouri’s upcoming legislative session to be filled with much more work to be done on this issue, and he said he’s been asked by state leaders to continue taking the lead on cannabis-related legislation. If Congress allows full-spectrum products, Missouri will have to approve that use through a bill. And if there is further delay of the federal ban, then lawmakers will have to pass regulations on beverages. “If they make a change in the drinks, then this is something we will have to look at in January…putting a framework around specifically the drinks,” Hinman said. “If we need to make changes and adjustments, I will absolutely be involved in this.” Panic for patients Hurford said the marijuana industry was born out of creating medicinal, therapeutic products. However, now dispensaries are often more focused on recreational products, she said, and offer an environment that might be intimidating for patients to enter and find what they need. “Let’s get back to promoting the medicinal aspects in those products,” she said. Healer is an example of a company that has helped her patients, and she believes its co-founder, Dr. Dustin Sulak, is a “well-respected, knowledgeable clinician.” But its products will be banned in November, and company owners say they won’t pursue trying to work within the marijuana regulations. Healer’s co-founder and CEO, Brad Feuer, said marijuana cultivation facilities nationwide focus on growing cannabis with high THC and low CBD content, which doesn’t work with their formula. And secondly, it wouldn’t be cost effective for the company or patients. Katherine Golden is a nurse who seven years ago founded an independent cannabinoid health hotline called Leaf411. She said while more medicinal products with only one or two milligrams of THC were available in dispensaries when her hotline first started, many of them have been pulled off the shelves. “That to me is the heartbreak of what’s happening with our legislation because you’re taking access away from a product that is not being abused,” Golden said. “The hemp market—those who are the responsible players—are providing this product that the retailers aren’t carrying because it doesn’t sell enough for them.” Part of the reason is because these customers need it delivered to their homes, particularly those caring for people with dementia or those struggling with ailments, she said. Her hotline has already gotten a taste of the panic patients may feel in November after California’s ban was put in place in July. “I can only guess when we see another state like Missouri ban on Nov. 12, we’re going to hear from Missourians calling us saying, ‘What do I do? I just found this out,’” she said. “Because a lot of patients are so involved in what they’re doing in their lives, they’re not following what’s happening.” Andrew Mullins, executive director of the Missouri Cannabis Trade Association that represents the state’s marijuana businesses, said for patients to be protected, their medical products must be “tested, taxed, age-gated and responsibly packaged, which simply isn’t happening with intoxicating hemp.” “Many dispensaries already carry low-dose THC products,” Mullins said, “and we expect there will be more emphasis on medicinal uses of their products and development of additional products to meet patient demand, as online and unregulated channels diminish.” Adrian Holguin, a California-based cannabis consultant under his business CannaShark, said Missouri’s regulatory framework ties the hands and potential profits of businesses working in intoxicating hemp and low-dose, full-spectrum. Like Healer, most of these businesses will choose to not to find a place in Missouri’s market. “They have to take their operations and either leave the state and find the last remaining states,” he said, “or they have to be ready to pivot in a direction that’s going to make sense and that follows the legislation that’s coming.” Business owners could try to work with a licensed Missouri marijuana manufacturer or cultivator to make their products under the new law. However, even for marijuana companies, Missouri is “a tough state to crack,” he said, partly due to the consolidation of facility licenses. Other states are going to be more accommodating. “When you decide on business,” he said, “where to play is one of the main questions you ask yourself.” Grigaitis believes this moment is going to produce challenges, but it’s also going to push innovation. Mighty Kind is looking to launch a new seltzer with Lion’s Mane mushroom concentration, he said, which promotes relaxation, focus and brain support. “I see it as all very positive,” Grigaitis said, “you know, evolution of moving from alcohol to something less harmful for everybody and plant magic of all kinds.” This story was first published by Missouri Independent. The post Missouri Moves Ahead With Hemp THC Product Restrictions As Federal Ban Is Delayed, But May Reassess In 2027 appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

This is my first visit to your web journal! We are a group of volunteers and new activities in the same specialty. Website gave us helpful data to work. editoto.ink

That is really nice to hear. thank you for the update and good luck. portaltaurino.com

Our commitment is to your complete happiness and deep satisfaction. Find Escort Service Laxmi Nagar for an adventure that feels both daring and safe. Our companions offer physical elegance and intimate conversation that captivates your soul. We create a fantasy atmosphere where pleasure is paramount, and every touch promises an orgasmic journey.

This is my first visit to your web journal! We are a group of volunteers and new activities in the same specialty. Website gave us helpful data to work. koi toto

Our Escort in Connaught Place are more than just companions—they are artists of pleasure, ready to fulfill your every desire. Each encounter is a unique journey tailored to your preferences for maximum satisfaction.

“If licensed adult-use retailers disappear, consumers will continue to seek cannabis through other channels… None of the alternatives will produce the safe and regulatory tested products, jobs and tax revenue the current legal market generates.” By Steve Reilly, Insa If you are a Massachusetts voter who has not been following the debate over cannabis policy, Question 8 on this November’s ballot deserves your attention. The measure asks voters whether Massachusetts should repeal the laws that allow and regulate adult-use cannabis sales. The implications go well beyond whether a dispensary remains open. The question reaches the system of licensed businesses, product testing, taxation and regulatory oversight that Massachusetts has built over the past decade—seeking to eliminate 27,000 jobs and $300,000,000 in tax revenue that will need to be made up somewhere else. Understanding what is actually being proposed and what would replace the current system is essential before casting a ballot. Massachusetts voters approved adult-use marijuana legalization in 2016. Since then, the commonwealth has developed a regulated market overseen by the Cannabis Control Commission (CCC), with licensed cultivators, manufacturers, retailers and testing laboratories operating under regulated state rules. Although there have been documented issues with regulatory oversight, the legislature recently took action to make improvements, and the ballot question could ultimately undermine that progress rather than build on it. Question 8—formally titled “An Act to Restore a Sensible Marijuana Policy”—would repeal the state laws governing the possession, distribution, cultivation and taxation of adult-use marijuana. While the medical market would remain legal and adults 21 and older would still be permitted to possess up to one ounce without civil or criminal penalties, possession of more than one ounce and up to two ounces would carry a civil penalty. The effect would be to penalize possession over an ounce, while keeping lesser amounts fully legal but eliminating the commercial dispensaries where product can be purchased. The practical effect will be to sow confusion and chaos with regards to what cannabis you can possess and where you can obtain it, likely pushing consumers into the illicit market. This is intentional by those brining the initiative who hope to diminish public support. A “yes” vote is not simply a vote to change cannabis regulations or impose new restrictions on dispensaries. It would eliminate the existing adult-use retail system. So what does that mean for consumers? Today, an adult-use consumer can enter a licensed Massachusetts cannabis retailer and purchase products that are subject to state requirements for testing, labeling, packaging, security and business oversight. The regulated system also establishes rules around who can sell cannabis and where it can be sold. If Question 8 passes, that licensed adult-use retail structure would go away, giving way to an unregulated market where these products continue to be legal to possess and use. The practical question for consumers is not whether cannabis possession remains legal, rather it is whether Massachusetts will continue providing a commercially regulated, licensed place for adults to purchase cannabis products. That raises important public-safety questions. There is also an economic consequence. Since legalization, Massachusetts’s adult-use cannabis market has generated more than $10 billion in cumulative sales, including approximately $1.65 billion in 2025 alone. In 2025, the cannabis industry generated approximately $308 million in state revenue and another $51 million in local-option tax revenue for municipalities that supports cultivation and manufacturing employees, laboratory workers, security companies, construction and real estate businesses, technology providers, professional services and other vendors. Eliminating the adult-use licensing and taxation framework would fundamentally alter the businesses and public revenues that have developed around it. One of the central arguments for legalization was that a regulated marketplace could provide adults with an alternative to an illicit market. But if licensed adult-use retailers disappear, consumers will continue to seek cannabis through other channels. Whether that means medical dispensaries, personal cultivation, transfers between adults or illicit sellers will depend on how the market responds. None of the alternatives will produce the safe and regulatory tested products, jobs and tax revenue the current legal market generates. As a registered voter, the choice on Question 8 is consequential. Question 8 represents a decision between maintaining a regulated adult-use marketplace that has existed for nearly a decade and moving Massachusetts toward a different model in which marijuana remains legal but unregulated. As voters consider the question, they should look beyond campaign slogans and understand exactly what the initiative would change, what protections would remain, what would disappear and how those changes could affect consumers, communities, employees and businesses. Cannabis policy should ultimately be about public safety, responsible access, accountability and informed consumer choice, not an unregulated free-for-all market. Whatever position a voter takes on Question 8, that decision should begin with a clear understanding of what is actually on the ballot. More information is available at at stoptherepealma.com. Steve Reilly is head of government relations for Insa, a cannabis company that operates in Massachusetts and other states. The post What Massachusetts Cannabis Consumers Need to Know About Question 8, The Ballot Measure To Roll Back Legalization (Op-Ed) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

“Kuehn did not have either taxpayer standing or standing for a matter of great public concern to challenge the constitutionality of the acts.” By Zach Wendling, Nebraska Examiner The Nebraska Supreme Court on Friday decided a longtime medical cannabis opponent will not have another day in court to try to overturn the state’s voter-approved medical cannabis laws, at least for now. Chief Justice Jeffrey Funke, in a unanimous 29-page ruling, agreed with a lower court judge’s decision that former state Sen. John Kuehn of Heartwell did not have standing to challenge Nebraska’s medical cannabis laws. Kuehn argues that such state laws, including Nebraska’s voter-enacted legalization of medical cannabis, are “preempted” by federal law under the U.S. Constitution’s supremacy clause defining marijuana as a more dangerous drug that states are precluded from regulating. “We conclude that Kuehn did not have either taxpayer standing or standing for a matter of great public concern to challenge the constitutionality of the acts,” Funke wrote. “We therefore affirm the district court’s order dismissing Kuehn’s operative complaint without prejudice.” “Without prejudice” means Kuehn could bring a similar case in the future if circumstances change. For instance, since June 2025, the Nebraska Legislature has appropriated more funds to the Nebraska Medical Cannabis Commission and passed new legislation around cannabis. What is ‘standing’? For a case to proceed, a litigant must prove they’ve suffered an “injury in fact” by the time a case is filed or later amended. Kuehn filed his case in December 2024 and last amended it June 2025. Kuehn conceded he had not yet suffered the direct injury but sought to use exceptions. “Standing refers to whether a party had, at the commencement of the litigation, a personal stake in the outcome of the litigation that would warrant a court’s exercise of its subject matter jurisdiction and remedial powers on that party’s behalf,” Funke explained in the opinion. Lancaster County District Judge Susan Strong dismissed Kuehn’s case on June 26, 2025. She also presided over and ruled against a preelection challenge from Kuehn, filed in September 2024. The Supreme Court last week affirmed Strong’s ruling on the validity of Nebraska’s medical cannabis laws, also in a unanimous ruling from Funke. Shifting federal guidance During oral arguments in April in Kuehn’s preemption appeal, no attorneys or justices asked about shifting federal guidelines on marijuana. U.S. Attorney General Todd Blanche federally downgraded state-licensed medical cannabis to a Schedule III drug in April, down from a Schedule I drug. Schedule I drugs, such as heroin, LSD, ecstasy and peyote, are drugs the federal government has classified as having a high likelihood of abuse and no currently accepted medical value. Schedule III drugs are defined as those with moderate to low potential for physical and psychological dependence, such as Tylenol with codeine, ketamine and testosterone. Nebraska’s Medical Cannabis Commission is working toward implementing a state-licensed program and has licensed four cultivators. Nebraska Gov. Jim Pillen (R) and Attorney General Mike Hilgers (R) signed off on a first set of regulations for the commission this summer. The commission is rewriting its regulations to add fees before moving to license product manufacturers or dispensaries. The Legislature authorized the commission to do so this year. Access to legally purchase medicine in Nebraska is still months, if not at least a year, away. Standing exceptions Kuehn tried to use two “narrow” exceptions to the standing rule: that he should be able to sue to try to prevent an “illegal expenditure” of public funds (taxpayer standing) or because the laws constitute a “matter of great public concern” (“great public concern standing”). “It is not enough to wait for the United States government to one day come to Nebraska and challenge these acts,” Kuehn’s attorney Eddie Greim of Missouri had told the justices. “Instead, Nebraska’s courts should be open to Nebraskans who want to hold their Nebraska state government to its constitutional limitations.” Funke wrote that other jurisdictions might find Kuehn had taxpayer standing, such as in other states, but Funke said doing so for Nebraska would be “inconsistent with our jurisprudence.” Funke also wrote that Kuehn’s claims did not present the “rare” circumstances to justify an exception for great public concern. Unlike in other taxpayer standing cases that try to block public spending alone, Kuehn sought to go further and declare the Nebraska medical cannabis laws unconstitutional. Had the case proceeded and later returned to the Supreme Court, it would take five justices to declare the laws unconstitutional. For standing, Kuehn needed a simple majority, or four judges. AG’s Office: Others could sue Zachary Pohlman, the state deputy solicitor general defending five state officials from Kuehn’s lawsuit, had argued that at least five parties would be better suited to sue than Kuehn, such as the federal government, Hilgers, a property owner, a prospective medical cannabis user or a criminal defendant charged with illegally possessing cannabis asserting the laws as a defense. The Supreme Court ruled that its finding whether Kuehn lacked standing was not related to whether others could sue in Kuehn’s place. Pillen was named in the suit, as were Secretary of State Bob Evnen, Department of Health and Human Services CEO Steve Corsi, former State Treasurer Tom Briese and Tax Commissioner Jim Kamm. Kuehn had also sued the 2024 ballot sponsors behind the voter-approved laws and current and former members of the Medical Cannabis Commission. The Nebraska Attorney General’s Office had threatened to sue the state Medical Cannabis Commission if it issued licenses. But no such challenge materialized when the commission licensed the first cultivators in October 2025. No other state lawsuits have been filed at this time. Hilgers’s office has joined a federal lawsuit seeking to challenge the DOJ’s rescheduling of marijuana, which President Donald Trump is calling for. In an unsigned statement Friday, Nebraskans for Medical Marijuana said another “desperate lawsuit, designed to erase the will of Nebraska voters and destroy medical cannabis, has failed.” “For nearly two years, people with powerful political connections and deep pockets have thrown everything they can at us,” the statement said. “Lawsuits, accusations, obstruction and delay, because they refuse to accept what 71 percent of Nebraskans overwhelmingly decided.” The group, which led the 2024 effort to legalize and regulate medical cannabis, said no matter the money, influence or political power behind the “next attack,” it won’t erase that vote. The next Medical Cannabis Commission meeting is Monday. This story was first published by Nebraska Examiner. Photo courtesy of Mike Latimer. The post Nebraska Supreme Court Rejects Another Challenge To Voter-Approved Medical Marijuana Law appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

I really like your take on the issue. I now have a clear idea on what this matter is all about.. toto

Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. believes there will be an “enormous demand” for psychedelic therapies as they become legally available, and he thinks President Donald Trump is unique among his predecessors in championing the issue. The secretary was speaking on the latest episode of a podcast he hosts for HHS in which he interviewed Bryan Hubbard, the CEO of Americans for Ibogaine. “One of the challenges that we will also face in the federal government [is] there’s going to be a demand for it,” Kennedy said of psychedelics. “If we do get it to the point where where it becomes available for veterans, there’s going to be an enormous demand for it and you need for every veteran treated approximately more than 100 hours of support staff. So there’s an expense attached to it.” The secretary also cited an executive order that Trump signed earlier this year to streamline research and access into psychedelic medicine. “I can’t picture any other president in American history who would have done what he did. He turned on a dime,” Kennedy said. “He got it in his head that this was something that he wanted to do.” “He talked to some of the veterans who you met in the Oval Office during the executive order signing. And Joe Rogan introduced him to some of those veterans and he just became convinced,” he said, referring to the popular podcaster who texted the president about psychedelics just days before he decided to sign the order. “I think he broke down a lot of barriers in doing that.” The president’s move “opens up all kinds of possibilities or and pathways for evidence-based research into psychedelics,” Kennedy said. Kennedy, who once said he had a “wonderful experience” on LSD while trying to see dinosaurs as a teenager, said he thinks that “most Americans” view psychedelics with a kind of negative bias. “This was hippie stuff from back in the 60s and that it was recreational,” he said of their view. “And it’s not really kind of a legitimate therapeutic treatment.” The secretary admitted that he himself is surprised to hear stories of people taking ibogaine once and changing their lives without having to use it again. “It’s hard for me to believe that you can do something once and…that you can then live off the laurels of that kind of spiritual realignment, that you don’t have to do something you know renew it on a daily basis,” he said. Could psychedelics change the way we treat opioid addiction?@w_bryan_hubbard has spent years fighting the opioid crisis and advocating for rigorous research into psychedelic medicine. On #TheSecretaryKennedyPodcast, we discuss ibogaine, addiction, veterans, the promise and… — Secretary Kennedy (@SecKennedy) September 10, 2026 Kennedy said earlier this year that the Trump administration is “very anxious” to create a pathway for access to psychedelics therapy and that top officials across federal agencies want to “get it out to the public as quickly as possible.” In an interview on the Joe Rogan Experience in February, Kennedy said he’s confident “we’re going to get it done,” with plans to develop and finalize rules that would enable patients with conditions such as post-traumatic stress disorder (PTSD) and depression to access psychedelic substances like psilocybin and MDMA in a “very controlled setting.” “Everybody in my agency…is very anxious to get a rule out there that will allow these kind of studies and will allow access under therapeutic settings, particularly [for] the military soldiers who have suffered these injuries to get access to these products,” the HHS secretary said. “We’re working through that process now. We’re all working on it and trying to make it happen.” “I think that we’re going to get it done,” he said. President Trump opened a new chapter in psychedelic medicine by creating pathways for rigorous, evidence-based research into these promising therapies. On the latest episode of #TheSecretaryKennedyPodcast, @w_bryan_hubbard and I discuss what this moment could mean for the future… pic.twitter.com/oC2HnzT1zp — Secretary Kennedy (@SecKennedy) September 10, 2026 Last June, Kennedy said his agency is “absolutely committed” to expanding research on the benefits of psychedelic therapy and, alongside of the head of FDA, is aiming to provide legal access to such substances for military veterans “within 12 months.” Veterans Affairs Secretary Doug Collins also disclosed in April that he had an “eye-opening” talk with Kennedy about the therapeutic potential of psychedelic medicine. And he said he’s open to the idea of having the government provide vouchers to cover the costs of psychedelic therapy for veterans who receive services outside of VA as Congress considers pathways for access. Last month, the Substance Abuse and Mental Health Services Administration issued a report on recent advances in psychedelic medicine, along with recommendations for state policymakers on how to prepare for formal approval of drugs like psilocybin and MDMA. It also noted how the Schedule I status of many psychedelics has hampered scientific studies on their effects for decades. HHS and VA recently announced a partnership to collaborate on research and development of psychedelic medicines to treat people struggling with serious mental health conditions. Separately, the Food and Drug Administration (FDA) issued finalized guidance to help researchers studying the therapeutic benefits of psychedelics navigate the “unique challenges” of such investigations. The agency also announced it will be holding a public hearing on psychedelic therapy issues in September. Previously, FDA and HHS in April announced steps that they say will help with “accelerating” therapeutic access to psychedelics for patients dealing with serious mental health conditions. In May, a bipartisan coalition of 32 members of Congress sent a letter urging FDA to expedite ongoing reviews of psychedelic therapies. Lawmakers recently filed a new bill that would require the Department of Defense (DOD) to evaluate how ongoing research on the therapeutic benefits of psilocybin could help members of the military. A separate recently introduced bipartisan measure is intended to codify Trump’s psychedelics executive order into law. An amendment adopted as part of the National Defense Authorization Act would extend a psychedelics research effort at DOD for an additional six years. The post There Will Be ‘Enormous Demand’ For Psychedelic Treatments, RFK Says, Praising Trump’s Action On The Issue appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

A medical marijuana dispensary owner in Mississippi is planning to fight a decision by the Drug Enforcement Administration (DEA) that she says could force her to fire two good employees if she wants to register for federal protections in line with the Trump administration’s move to federally reschedule cannabis. Nicole Huff, CEO of the Wildflower Medical Dispensary in Aberdeen, shared with Marijuana Moment correspondence that a DEA official sent about the two workers in question, who have past felony convictions. As a result of those criminal records, the business must either fire the employees, withdraw its application for federal protections, seek a waiver while becoming ineligible for expedited processing or go before an agency judge. “I am frustrated and disappointed that, after these two individuals have worked for me for more than a year without any issues or disciplinary actions, the DEA would require me to remove them from their positions,” Huff told Marijuana Moment. Ashlie Way, a diversion investigator with DEA’s Jackson District Office, sent Huff an email last Thursday saying that “because you have the 2 employees who have felony convictions, you have the following options when it comes to your application.” “You can waive your right to the expedited application in the event you want to proceed with an employment waiver,” it said. “Or you can withdraw your DEA application.” “If you choose not to do either of those, I will send your application up for what we call an Order to Show Cause. An Order to Show cause is when an application is sent to Headquarters. They will assign it to an attorney who will send out a letter to the applicant letting them know that they have the right to request a hearing. If they choose to have a hearing, the applicant will respond to the letter, and a hearing will be set for them before the Administrative Law Judge (ALJ). I believe the hearing is held in Washington DC. The applicant will then have the opportunity to present their case to the ALJ. From there, the Judge will determine if the application proceeds to a registration or if the application will be denied.” The email said the dispensary would need to make a decision by no later than the close of business four days later—on Monday, which was Labor Day. Huff told Marijuana Moment that she will take the issue before a DEA judge. “I plan to request employment waivers on their behalf,” she said. “I understand that doing so may require me to travel to Washington, D.C., and appear in federal court, and I am prepared to take the necessary steps.” “It is already extremely difficult for individuals with nonviolent felony convictions to obtain stable employment. I intend to ask the court to consider a grandfather provision for individuals who were employed before the DEA application was submitted,” Huff said. “If an employee has a nonviolent conviction, has maintained satisfactory employment and has received no disciplinary actions, I believe that person should be eligible for an exemption from mandatory removal.” The two Wildflower workers in question “have demonstrated their reliability through more than a year of successful employment,” she said. “I plan to ask that their individual circumstances and employment records be considered before a final decision is made. I hope other dispensary owners would do the same.” Huff didn’t directly respond to Marijuana Moment’s question about what kind of felony convictions her employees have. Marijuana Moment also reached out to DEA about the number of applications for registration it has received to date and how many of those are being similarly held up due to workers’ criminal records, but a representative did not respond. DEA regulations for registration to handle controlled substances state that “the registrant shall not employ, as an agent or employee who has access to controlled substances, any person who has been convicted of a felony offense relating to controlled substances.” The agency does, however, allow employers to submit requests for waivers. “A waiver will not be considered unless there are valid reasons to believe that diversion is unlikely to occur,” a DEA manual says. The agency will weigh several factors in making its determination on a waiver, it says: A detailed description of the nature and extent of the individual’s past controlled substances violations, including all pertinent documentation; Current status of the individual’s state licensure; Extent of individual’s proposed access to controlled substances. “Access” is not limited to only physical access to controlled substances, but includes any influence over the handling of controlled substances; Registrant’s proposed physical and professional safeguards to prevent diversion by the individual; Status of employing registrant regarding handling of controlled substances; Other pertinent information uncovered by DEA in its investigation of the individual’s or registrant’s handling of controlled substances; and All other relevant factors or materials. In Huff’s case, even if she asks for and receives a waiver, she will still have to waive her right to the agency’s expedited application process for registration for the federal benefits and protections that come with rescheduling, according to Way’s email. Meanwhile, the agency has been conducting inspections and follow up interviews with medical cannabis businesses that register for federal protections, but industry sources say the way the agency has been carrying out those activities varies between DEA’s regional offices throughout the country. In June, Mississippi medical cannabis businesses spoke to Marijuana Moment about being visited by DEA officials, who told them they were among the first in the country to be seen for inspection under the registration process. Last month, Marijuana Moment obtained a list of 26 questions that DEA officials are sending to medical cannabis businesses in Colorado as part of the consideration of their applications for registration. The questions on the form being sent to Colorado businesses include: Will you be ordering marijuana or marijuana products from other states? Will you be ordering synthetic cannabinoids? Will you be ordering marijuana seeds or plants in order to grow at the dispensary location? What are the specific types of products offered (e.g., gummies, extracts, concentrates, tinctures, topical products, oils, flower buds, oil cartridge vapes, dry herb vapes, pre-rolled cannabis cigarettes, etc.)? Please identify your medical marijuana supplier(s) to include name(s), address(es), and DEA registration number(s). Please provide a copy of any labeling, packaging, and sealing policies (refer to federal guidelines for medical marijuana packaging pursuant to Title 21 CFR § 1301.13(k)(8) which states that the label of all medical marijuana products shall, when dispensed to or for a patient, contain a clear, concise warning that it is a crime to transfer the drug to any person other than the patient). How is defective (e.g. mold, rot, bug infestation), expired, or discontinued/deadstock marijuana products disposed of? The agency launched its initial registration form for dispensaries in April, days after Attorney General Todd Blanche issued an order immediately moving marijuana products regulated by a state medical cannabis license from Schedule I of the Controlled Substances Act (CSA) to Schedule III, along with marijuana products that are approved by the Food and Drug Administration (FDA). A DEA hearing that recently concluded testimony is considering broader marijuana rescheduling. Meanwhile, the agency said it plans to launch new forms for additional types of state-licensed medical marijuana businesses beyond dispensaries, such as manufacturers, distributors and laboratories. The currently available registration form for state-licensed medical marijuana dispensaries asks for information about their processes for storage, ordering, dispensing, inventory, maintenance of records and other aspects of their businesses. The application asks about specific details about security measures such as vaults, safes, secure storage rooms, access controls, alarm systems and on-site security personnel. Applicants can choose whether they are requesting to handle marijuana, marijuana extracts or naturally derived delta-9 THC. While only medical marijuana is currently being moved to Schedule III, the application also asks potential registrants whether their firms handle or dispense recreational marijuana. The DEA application also asks businesses to submit information about their state cannabis licenses and to answer questions about criminal and disciplinary histories. It also asks: “Has anyone who will be involved in the ownership or operation of the firm previously manufactured, distributed, and/or dispensed any controlled substance without a DEA registration authorizing such activity?” Presumably, every currently operational state-legal cannabis business has key personnel who have done so, since medical marijuana was, until recently, a Schedule I controlled substance that DEA did not broadly authorize manufacturing, distribution and dispensation of. Applicants must additionally list suppliers from which they intend to procure marijuana, and to disclose whether they anticipate repackaging or relabeling cannabis products. They also need to provide lists of individuals with the business that are anticipated to have “access to controlled substances,” including their dates of birth, social security numbers, criminal histories related to drugs. Photo courtesy of Mike Latimer. The post Marijuana Dispensary Owner Says DEA Is Forcing Her To Fire Workers In Order To Get Federal Protections Under Trump’s Rescheduling Move appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

We introduce you to beautiful, a lovely, curvaceous young Escorts in Dwarka who takes great pleasure in meeting her clients' requirements and realizing their most ambitious dreams. She is well appreciated for her remarkable attractiveness and outstanding customer service.

Congressman: WI can legalize marijuana in 2027; New IL medical cannabis licenses; Study: CBD for athletic recovery; CA marijuana packaging rules op-ed Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possible… Free to read (but not free to produce)! We’re proud of our newsletter and the reporting we publish at Marijuana Moment, and we’re happy to provide it for free. But it takes a lot of work and resources to make this happen. If you value Marijuana Moment, invest in our success on Patreon so we can expand our coverage and more readers can benefit: https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW A newly updated report from the U.S. Census Bureau shows that states have collected more than $15.8 billion in marijuana tax revenue over the past five years—including more than $3.5 billion in the last year. “And the numbers keep growing,” the federal agency said. Rep. Mark Pocan (D-WI) told Marijuana Moment that his home state of Wisconsin is poised to legalize marijuana next year—especially if his party wins control of the legislature in the November elections, but perhaps even if Republicans maintain a majority under new leadership for the 2027 session. The Illinois Department of Financial and Professional Regulation issued new licenses to 37 existing recreational marijuana dispensaries that will now allow them to also sell medical cannabis—which officials called the “biggest expansion of the medical cannabis market in Illinois since 2016.” A new scientific review of CBD use by athletes found that it “supports post-exercise recovery depending on dosage and delivery but does not directly enhance performance.” “Oral or sublingual CBD reduces biochemical markers of muscle damage (creatine kinase, myoglobin) and subjective delayed-onset muscle soreness (DOMS) within 48-72 h post-exercise.” CannaShark Consulting’s Adrian A. Holguin argues in a new Marijuana Moment op-ed that California cannabis businesses should start taking action now to comply with the state’s new packaging rules, even though they don’t take effect until 2028. “Artwork gets locked with the printer weeks or months before the run. Then the boxes sit in a warehouse until they are used.” / FEDERAL President Donald Trump again pledged to institute the death penalty for some people who sell illegal drugs. Rep. Lou Correa (D-CA) tweeted, “Our veterans took an oath to defend this country — making the ultimate sacrifice if necessary. Many bring back the invisible scars of the battlefield, with an estimated 20 to 40 veterans take their own lives every day. Congressional lag on advancing psychedelic therapy treatments cannot be tolerated. This medicine works. This medicine saves veteran lives. The time is NOW to deliver the proper care that our veterans need to heal from the invisible wounds of trauma. It’s the least we can do to thank America’s heroes for their service.” / STATES The Kentucky legislature’s Administrative Regulation Review Subcommittee held a hearing on medical cannabis issues. A federal judge rejected a lawsuit challenging Connecticut hemp restrictions. A New York appeals court held a hearing on a lawsuit challenging the state’s marijuana social equity business financing policies. California regulators announced a recall of marijuana products because the cannabis used to make them was produced under unsanitary conditions and that the cultivation practices did not conform with pesticide statutes and regulations. Missouri regulators posted the results of a random lottery drawing of marijuana microbusiness license applicants. Maryland regulators issued a request for information from nonprofit organizations interested in managing the state’s Cannabis Incubator Facility. Oklahoma regulators issued a warning about fraudulent scam emails targeting medical cannabis businesses. New Jersey regulators took action on marijuana business licensing and disciplinary issues. The Nevada Cannabis Advisory Commission will meet on Monday. The Alaska Marijuana Control Board will meet on September 22. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — / LOCAL Champaign County, Illinois is using marijuana revenue to fund Flock cameras. / SCIENCE & HEALTH A study found that “purified CBD was efficacious in a broad range of pediatric epilepsies, and was well tolerated as an adjunctive antiseizure medication.” A review concluded that “psilocybin-assisted therapy may reduce heavy alcohol consumption in some individuals with” alcohol use disorder. / ADVOCACY, OPINION & ANALYSIS The Global Commission on Drug Policy published a brief advocating that the rights, needs, experiences and voices of children and young people be included in the development of drug policy. The Hemp Beverage Alliance elected new board of directors members. / BUSINESS Records related to Curaleaf and its investment transactions are reportedly being investigated by the British Columbia, Canada Securities Commission. Shield Compliance published a survey of cannabis business operators’ views on rescheduling, hemp and banking. Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox. Get our daily newsletter. Email address: Leave this field empty if you're human: The post Feds highlight cannabis tax revenue earned by states (Newsletter: September 11, 2026) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Watching these elegant ladies prepare drinks while wearing nothing but your shirt creates instant arousal. They move with feline grace around the room, occasionally brushing against you intentionally. Their teasing nature keeps you on edge beautifully. Book Escort in Saket for encounters that balance sophistication with raw passionate energy.

Who says indulgence must break the bank? Bangalore Call Girls Service brings passion within reach in the most delightful way. From her first smile, I knew this wasn't transactional—it was pure chemistry. The perfect blend of sophistication and raw desire that every discerning gentleman secretly dreams about.

Illinois officials have issued new licenses to 37 existing recreational marijuana dispensaries that will now allow them to also sell medical cannabis. The expanded opportunity for marijuana businesses comes as part of omnibus cannabis legislation that was passed by lawmakers and signed into law by Gov. JB Pritzker (D) this session. Last month, the Illinois Department of Financial and Professional Regulation (IDFPR) posted a new form that adult-use marijuana dispensaries can fill out in order to get permission to begin selling medical cannabis, which is taxed at a much lower rate than adult-use products. IDFPR said in a press release on Thursday that the new move “greatly increases patient access across the state, while also eliminating unnecessary red tape for regulators and consumers alike.” It additionally gives newer dispensaries approved under social equity lotteries the chance to serve medical patients, “leveling the playing field for small businesses.” “Expanding access to medical cannabis is an important step toward ensuring Illinois patients have more options to obtain the medicine they rely on,” Mario Treto, Jr., secretary of IDFPR, said. “More dispensaries means better options and increased convenience for medical patients, while still maintaining the regulatory safeguards that protect patients and promote a safe and responsible cannabis industry.” Erin A. Johnson, the state’s cannabis regulation oversight officer, said “this is a monumental day for medical patients, who have long advocated for these changes.” The news of the state’s approval of the new medical cannabis licenses was first reported by The Cole Memo. Additional licenses will be issued on a continuing basis, officials said. The recently enacted law that allows the new medical licenses also doubles the amount of marijuana that adults can legally possess, allows drive-thrus and curbside pickups at dispensaries and lets them stay open for longer hours of operation, among other changes. It is the “biggest expansion of the medical cannabis market in Illinois since 2016,” IDFPR said. Rep. Bob Morgan (D), who championed the recently enacted marijuana bill, said that “expanding the number of dispensaries able to serve medical cannabis patients is good policy for Illinois.” “It means patients have greater access and more choices, while dispensaries have new opportunities to grow their businesses and better serve their communities,” he said. This is an important step toward building a stronger, more accessible medical cannabis program in Illinois.” IDFPR said in previously issued guidance about changes made by the new cannabis omnibus legislation that “any adult use dispensary holding an active license in good standing may opt-in for a medical dispensary license,” which will allow it to “sell cannabis to medical cannabis patients at the medical tax rate up to the medical patient’s allotment.” The medical cannabis sales option for adult-use businesses is part of SB 3222, which was approved by the legislature and signed by Gov. JB Pritzker (D) in June. As enacted into law, the measure also allows residents of the state who are over 21 years of age to possess up to 60 grams of marijuana flower—double the amount in prior law. They are also able to have up to 10 grams of cannabis concentrates and infused products with up to 1,000 mg of THC—also double the earlier limit. Possession amounts for adult non-residents are also doubled under the bill and are generally set at half of what residents can carry. Additionally, people with past convictions for possession of up to 60 grams of marijuana are now able to have those records expunged—double the previous cutoff allowing only those with convictions for up to 30 grams to be eligible. The legislation also recriminalizes hemp THC products with more than 0.4 milligrams of THC per container, in line with a federal ban that is set to take effect in November. The state’s list of medical marijuana qualifying conditions was also expanded to add female orgasmic disorder, endometriosis, ovarian cysts and uterine fibroids by the bill. Last month, Illinois regulators separately added sickle cell disease and polyendocrine metabolic ovarian syndrome (PMOS) with chronic pain as new medical cannabis qualifying conditions. The governor held a signing ceremony for the cannabis expansion legislation at a marijuana dispensary, saying he is “proud that Illinois continues to lead the nation in showing what thoughtful, balanced cannabis policy can achieve.” In 2019, Pritzker signed the state’s initial marijuana legalization policy into law. The post Illinois Officials Approve More Dispensaries To Sell Medical Marijuana As Part Of The ‘Biggest Expansion’ Of The State’s Market In A Decade appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

“2028 sounds far away. But artwork gets locked with the printer weeks or months before the run. Then the boxes sit in a warehouse until they are used.” By Adrian A. Holguin, CannaShark Consulting Last month, California Gov. Gavin Newsom (D) signed AB 2249, a bill that puts a much clearer line around what cannabis packaging, labels and ads can look like. The short version: no child-oriented dragons, unicorns or wizards; nobody who looks under 21; no imagery of candy, cereal, sweets or desserts primarily marketed to children; no child-style bubble or balloon lettering; and no packaging that mimics a noncannabis product marketed to kids. The new definition takes effect on January 1, 2028. Most of the coverage stopped there, and I get it. “Rules take effect in sixteen months” doesn’t make anyone spill their coffee. But operators tend to call me after a rule costs more than they expected, so here’s why 2028 is not the date that matters. First, the basics. California has banned cannabis packaging that is “attractive to children” since legal sales began, and cartoons on labels are already prohibited. The problem was that the line remained subjective and was applied inconsistently. A 2025 state audit found that Department of Cannabis Control (DCC) rules were not specific enough and that reasonable reviewers sometimes reached different conclusions about similar packaging. AB 2249 draws a clearer line. It defines “attractive to children” as designed or likely to appeal to anyone under 21, then identifies cartoons; depictions of people under 21; celebrities, influencers, characters and mascots primarily associated with contemporary children’s media or products; fantasy characters such as unicorns, wizards and dragons; imagery of candy, cereal, sweets and desserts primarily marketed to children; child-oriented bubble or balloon lettering; and packaging that mimics a noncannabis product marketed to children. Cartoon or overly stylized fruit on an edible or vape label is out. A realistic depiction of fruit that accurately reflects an ingredient or production region is allowed. The bill also authorizes DCC to adopt additional rules for design elements or product characteristics that pose a heightened risk to children, and it requires the department to develop self-assessment resources. DCC launched its AI-based Cannabis Product Image Analyzer in June. Use it as a screening tool, not a safe harbor: an automated result is advisory, not a final DCC determination. AB 2249 sets no deadline for additional rulemaking or for the required resources, so operators are still designing against a target that could move. Now here’s the part that got underplayed. Packaging isn’t bought like office supplies. Many brands buy it in runs representing six months to a year of inventory because that is how they protect unit economics. Artwork gets locked with the printer weeks or months before the run. Then the boxes sit in a warehouse until they are used. So play it forward. A brand placing a normal-sized packaging order in early 2027 may be buying stock it expects to use well into 2028. AB 2249 contains no express sell-through safe harbor for old packaging. Unless DCC issues contrary guidance, the prudent plan is to assume that product offered for sale on January 1, 2028 must comply with the new definition. That may put the artwork deadline in late 2026. In other words, somebody has to decide now whether the mascot stays. The California Cannabis Industry Association opposed the bill on cost, and that concern is real. A redesign can mean compliance review, new plates, minimum order quantities, retailer notifications and eventually paying someone to destroy old packaging. But the final Senate vote was 38-0, and the Assembly concurred 69-1. The cost is now a scheduling problem, and scheduling problems are only cheap if you start early. Handled on the front end, this is a calendar and a manageable cost. Handled on the back end, it becomes destroyed inventory, retailer disruption, potential enforcement and a bill with more zeros. The difference is almost never information. Operators knew the rule was coming. The problem is that “2028” sounds far away. If you hold a California license, this quarter looks like this: pull every SKU and flag anything with a character, creature, candy cue, child-oriented lettering or stylized fruit. If you have to argue about whether the gummy bear is a cartoon, it probably is. Get your printer’s real lead times in writing and work backward from January 1, 2028. Start the redesign conservatively, have the final art reviewed, and run it through DCC’s tool as a screen before the plates are cut. Then size your last old-look order to sell through before 2028. Nobody should build a compliance plan around the hope that the state will be generous with a pallet of dragon gummies. The state gave you sixteen months. Your printer gave you about six. Plan around the printer. Adrian A. Holguin, J.D., M.B.A., is founder and president of CannaShark Consulting. He advises cannabis operators and businesses in other highly regulated industries on licensing, compliance, finance and operations, and also serves as an expert witness. Photo courtesy of Max Pixel. The post California Marijuana Businesses Should Act Now To Comply With New Packaging Rules That Don’t Take Effect Until 2028 (Op-Ed) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Great article with excellent idea!Thank you for such a valuable article. I really appreciate for this great information.. Knee Massager Australia